40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
88.67%
Revenue growth above 1.5x MTDR's 39.92%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
189.76%
Gross profit growth above 1.5x MTDR's 86.93%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
1037.82%
EBIT growth above 1.5x MTDR's 118.21%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
1037.82%
Operating income growth above 1.5x MTDR's 118.21%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
2541.03%
Net income growth above 1.5x MTDR's 668.31%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
2595.00%
EPS growth above 1.5x MTDR's 693.33%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
2595.00%
Diluted EPS growth above 1.5x MTDR's 693.33%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.18%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
No Data
No Data available this quarter, please select a different quarter.
-6.98%
Dividend reduction while MTDR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-36.84%
Negative OCF growth while MTDR is at 14.59%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-41.99%
Negative FCF growth while MTDR is at 81.23%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-71.76%
Negative 10Y revenue/share CAGR while MTDR stands at 1637.75%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
29.57%
5Y revenue/share CAGR under 50% of MTDR's 140.46%. Michael Burry would suspect a significant competitive gap or product weakness.
104.22%
3Y revenue/share CAGR under 50% of MTDR's 216.62%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-78.47%
Negative 10Y OCF/share CAGR while MTDR stands at 1032.12%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-6.30%
Negative 5Y OCF/share CAGR while MTDR is at 106.15%. Joel Greenblatt would question the firm’s operational model or cost structure.
10.34%
3Y OCF/share CAGR under 50% of MTDR's 514.66%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-24.74%
Negative 10Y net income/share CAGR while MTDR is at 4930.25%. Joel Greenblatt sees a major red flag in long-term profit erosion.
417.78%
5Y net income/share CAGR similar to MTDR's 406.52%. Walter Schloss might see both on parallel mid-term trajectories.
248.83%
3Y net income/share CAGR above 1.5x MTDR's 143.59%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
-74.49%
Negative equity/share CAGR over 10 years while MTDR stands at 110.89%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
12.04%
Below 50% of MTDR's 69.09%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
6.79%
Below 50% of MTDR's 154.21%. Michael Burry suspects a serious short-term disadvantage in building book value.
-96.59%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-74.19%
Negative 5Y dividend/share CAGR while MTDR stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-70.52%
Negative near-term dividend growth while MTDR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-35.11%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
0.17%
Asset growth well under 50% of MTDR's 9.55%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
14.88%
BV/share growth above 1.5x MTDR's 4.26%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-0.12%
We’re deleveraging while MTDR stands at 21.86%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-24.18%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.